Armata Pharmaceuticals (ARMP) Intangibles (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Intangibles of $10.3 million for Q1 2026, little changed sequentially from $10.3 million in Q4 2025, and little changed YoY from $10.3 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Intangibles (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Intangibles for 14 years, with the latest figure at $10.3 million in Q1 2026.
- Quarterly Intangibles changed 0.0% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (changed 0.0% YoY) and the FY2025 annual result came in at $10.3 million, changed 0.0% from the prior year.
- Intangibles steadied at $10.3 million in Q1 2026 per ARMP's latest filing, from $10.3 million in the prior quarter.
- Over five years, Intangibles peaked at $10.3 million in Q1 2022 and troughed at $10.3 million in Q1 2022.
- A 5-year average of $10.3 million and a median of $10.3 million in 2022 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 0.0% in 2022, down 0.0% in 2022.
- Over 5 years, Intangibles stood at $10.3 million in 2022, then changed by 0.0% to $10.3 million in 2023, then changed by 0.0% to $10.3 million in 2024, then changed by 0.0% to $10.3 million in 2025, then changed by 0.0% to $10.3 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $10.3 million, $10.3 million, and $10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | 10.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.26 Mn |
| Mar 31, 2026 | 10.26 Mn |
| Dec 31, 2025 | 10.26 Mn |
| Sep 30, 2025 | 10.26 Mn |
| Jun 30, 2025 | 10.26 Mn |
| Mar 31, 2025 | 10.26 Mn |
| Dec 31, 2024 | 10.26 Mn |
| Sep 30, 2024 | 10.26 Mn |
| Jun 30, 2024 | 10.26 Mn |
| Mar 31, 2024 | 10.26 Mn |
| Dec 31, 2023 | 10.26 Mn |
| Sep 30, 2023 | 10.26 Mn |
| Jun 30, 2023 | 10.26 Mn |
| Mar 31, 2023 | 10.26 Mn |
| Dec 31, 2022 | 10.26 Mn |
| Sep 30, 2022 | 10.26 Mn |
| Jun 30, 2022 | 10.26 Mn |
| Mar 31, 2022 | 10.26 Mn |
| Dec 31, 2021 | 10.26 Mn |
| Sep 30, 2021 | 10.26 Mn |